5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
India
The Asia-Pacific diabetes care devices market is expected to register a CAGR of about 7.8% during 2018-2023 (the forecast period). China is anticipated to dominate the market during the forecast period, due to the presence of huge diabetic patient pool in the region.
Asia-Pacific is the fastest growing region in the global market, due to the presence of a huge diabetic population. China and India contribute to major shares in the Asia-Pacific diabetes care devices market, due to the presence of heavy diabetic population. According to WHO, over 60% of the diabetic people in the world are living in Asia-Pacific, where India and China are the major contributing countries, with a diabetic population of 90 million and 62 million, respectively. By 2030, both of the countries together are expected to witness about a diabetic population of half a billion individuals. Therefore, growing diabetic and obese population across Asia-Pacific is driving the market growth. Additionally, innovative product development and growing awareness, regarding diabetic care, are the factors that are further driving the market for diabetes care devices in Asia-Pacific.
In India, approximately 10% of the population avails health insurance coverage and over 80% of the healthcare costs are out-of-pocket expenses.
Device manufacturers should be aware of the coverage limits and demographics while pricing their products, in order to capture the largest possible market share. For mature medical products, such as heart valves, stents etc., the coverage has been determined and the data is available for insurers. However, to develop new products, like glucose meters and diabetes devices, the coverage has not been established. Therefore, these products are available only to a limited people. Thus, a lack of reimbursement policies and high cost associated with diabetes care devices, in developing countries of Asia-Pacific, are likely to impede the market growth.
China is dominating the Asia-Pacific diabetes care devices market. The growth of the Chinese market can be attributed to the factors like rapid urbanization, high calorie diet, and physical inactivity, which are the major reasons for the high prevalence of diabetes in China. India is anticipated to grow tremendously during the forecast period. The growing prevalence of diabetes, rising awareness about diseases, changing food habits, and a rise in disposable incomes in the country are likely to augment the growth of the Indian diabetes care devices market.
Major Players: Abbott Laboratories, Acon Laboratories, Inc., Bayer AG, Becton, Dickinson and Company, Eli Lilly & Co., F. Hoffmann-La Roche Ltd, Johnson and Johnson, Medtronic Plc, Novo Nordisk A/S, and Sanofi, among others.
5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
India
+1 617-765-2493
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination.
Interested? Please email us
[email protected]© 2020. All Rights Reserved to Mordor Intelligence.